Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient Preferences for Psoriasis Treatments
Marthe‐Lisa Schaarschmidt
Archives of Dermatology (2011) Vol. 147, Iss. 11, pp. 1285-1285
Closed Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Discrete Choice Experiments in Health Economics: A Review of the Literature
Michael Clark, Domino Determann, Stavros Petrou, et al.
PharmacoEconomics (2014) Vol. 32, Iss. 9, pp. 883-902
Closed Access | Times Cited: 723
Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
Mark Lebwohl, H. Bachelez, Juliet N. Barker, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 5, pp. 871-881.e30
Closed Access | Times Cited: 486
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
Josef S Smolen, J. Braun, Maxime Dougados, et al.
Annals of the Rheumatic Diseases (2013) Vol. 73, Iss. 1, pp. 6-16
Open Access | Times Cited: 431
Outcomes associated with matching patients' treatment preferences to physicians' recommendations: study methodology
Nasir Umar, David Litaker, Marthe‐Lisa Schaarschmidt, et al.
BMC Health Services Research (2012) Vol. 12, Iss. 1
Open Access | Times Cited: 306
Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)
Jeffrey Crowley, Diamant Thaçi, P. Joly, et al.
Journal of the American Academy of Dermatology (2017) Vol. 77, Iss. 2, pp. 310-317.e1
Open Access | Times Cited: 168
Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review
Aleksandra G. Florek, Catherine J. Wang, April W. Armstrong
Archives of Dermatological Research (2018) Vol. 310, Iss. 4, pp. 271-319
Closed Access | Times Cited: 118
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis
Howa Yeung, Joy Wan, Abby S. Van Voorhees, et al.
Journal of the American Academy of Dermatology (2012) Vol. 68, Iss. 1, pp. 64-72
Open Access | Times Cited: 113
Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature
I. Belinchón, R. Rivera, Carles Blanch, et al.
Patient Preference and Adherence (2016) Vol. Volume 10, pp. 2357-2367
Open Access | Times Cited: 100
The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives
Steven R. Feldman, Bernard S. Goffe, Gary Rice, et al.
(2016) Vol. 9, Iss. 9, pp. 504-513
Closed Access | Times Cited: 100
Risk as an Attribute in Discrete Choice Experiments: A Systematic Review of the Literature
Mark Harrison, Dan Rigby, Caroline Vass, et al.
Patient (2014) Vol. 7, Iss. 2, pp. 151-170
Closed Access | Times Cited: 95
Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two‐stage qualitative and quantitative study
Anthony Bewley, D. M. Burrage, Steven Ersser, et al.
Journal of the European Academy of Dermatology and Venereology (2013) Vol. 28, Iss. 6, pp. 763-770
Open Access | Times Cited: 84
Preference for pharmaceutical formulation and treatment process attributes
Katie D. Stewart, Joseph A. Johnston, Louis S. Matza, et al.
Patient Preference and Adherence (2016) Vol. Volume 10, pp. 1385-1399
Open Access | Times Cited: 82
Patients’ Preferences for Outcome, Process and Cost Attributes in Cancer Treatment: A Systematic Review of Discrete Choice Experiments
Daniela R. Bien, Marion Danner, Vera Vennedey, et al.
Patient (2017) Vol. 10, Iss. 5, pp. 553-565
Open Access | Times Cited: 73
Patient preferences for psoriasis treatments: impact of treatment experience
Marthe‐Lisa Schaarschmidt, Nasir Umar, Astrid Schmieder, et al.
Journal of the European Academy of Dermatology and Venereology (2012) Vol. 27, Iss. 2, pp. 187-198
Closed Access | Times Cited: 63
Treatment Satisfaction of Patients with Psoriasis
Marthe‐Lisa Schaarschmidt, Christian Kromer, Raphael M. Herr, et al.
Acta Dermato Venereologica (2015) Vol. 95, Iss. 5, pp. 572-578
Open Access | Times Cited: 57
Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment
Christian Kromer, Marthe‐Lisa Schaarschmidt, Astrid Schmieder, et al.
PLoS ONE (2015) Vol. 10, Iss. 6, pp. e0129120-e0129120
Open Access | Times Cited: 57
Prevalence and characterization of treatment‐refractory psoriasis and super‐responders to biologic treatment: a nationwide study
Nikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 8, pp. 1284-1291
Open Access | Times Cited: 27
Comorbidities significantly impact patients’ preferences for psoriasis treatments
Astrid Schmieder, Marthe‐Lisa Schaarschmidt, Nasir Umar, et al.
Journal of the American Academy of Dermatology (2011) Vol. 67, Iss. 3, pp. 363-372
Closed Access | Times Cited: 52
Treatment Strategies Against Psoriasis: Principle, Perspectives and Practices
Arya Kadukkattil Ramanunny, Sheetu Wadhwa, Sachin Kumar Singh, et al.
Current Drug Delivery (2019) Vol. 17, Iss. 1, pp. 52-73
Closed Access | Times Cited: 40
Dermatologist and Patient Preferences in Choosing Treatments for Moderate to Severe Psoriasis
Matthew Alcusky, Seina Lee, Gordon Lau, et al.
Dermatology and Therapy (2017) Vol. 7, Iss. 4, pp. 463-483
Open Access | Times Cited: 38
Patient preference for biologic treatments of psoriasis in Japan
Yayoi Tada, Kanako Ishii, Junko Kimura, et al.
The Journal of Dermatology (2019) Vol. 46, Iss. 6, pp. 466-477
Open Access | Times Cited: 34
A systematic review on methods used to evaluate patient preferences in psoriasis treatments
M. Gutknecht, Marthe‐Lisa Schaarschmidt, O. Herrlein, et al.
Journal of the European Academy of Dermatology and Venereology (2016) Vol. 30, Iss. 9, pp. 1454-1464
Closed Access | Times Cited: 32
Patients’ preferences for the treatment of anxiety and depressive disorders: a systematic review of discrete choice experiments
Maike Tünneßen, Mickaël Hiligsmann, Stephanie Stock, et al.
Journal of Medical Economics (2020) Vol. 23, Iss. 6, pp. 546-556
Open Access | Times Cited: 30
Vaccine preferences driving vaccine-decision making of different target groups: a systematic review of choice-based experiments
Marilyn Emma Diks, Mickaël Hiligsmann, Van Putten
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 27
Patient-centred Preferences for Biologic Therapies in Moderate to Severe Psoriasis in Vietnam: A Discrete Choice Experiment
Chuyen Thi Hong Nguyen, Nguyễn Thị Xuân, Trung The Van
Acta Dermato Venereologica (2025) Vol. 105, pp. adv42840-adv42840
Open Access
Page 1 - Next Page

Scroll to top